You can buy or sell GALT and other stocks, options, and ETFs commission-free!
Galectin Therapeutics Inc. Common Stock, also called Galectin Therapeutics, is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease and cancer. Its programs target the development of carbohydrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA. The listed name for GALT is Galectin Therapeutics Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 16, Pre-Market